{"schemaVersion":"ready-scan.discovery-surface.v1","id":"urn:readyscan:corpus:evidence:probatix-health-gmbh-q140262414","key":"evidence:probatix-health-gmbh-q140262414","kind":"evidence","slug":"probatix-health-gmbh-q140262414","canonicalUrl":"https://directory.readyscan.ai/corpus/evidence/probatix-health-gmbh-q140262414","machineUrl":"https://directory.readyscan.ai/discovery/corpus/evidence/probatix-health-gmbh-q140262414.json","datePublished":"2026-07-29","dateModified":"2026-10-27","materialFingerprint":"fnv1a64:2a49e6591323f47f","membershipFingerprint":"fnv1a64:d9a424f625a1b6e9","relatedEntitySlugs":["probatix-health-gmbh-q140262414"],"relatedSurfaceKeys":["buyer_question:probatix-health-gmbh-q140262414-answer-084b48b1b916d580899e","buyer_question:probatix-health-gmbh-q140262414-answer-2995f99c2587dbc0f66e","buyer_question:probatix-health-gmbh-q140262414-answer-2fe4eda2125b74fff956","buyer_question:probatix-health-gmbh-q140262414-answer-41ffa69c2f83f3ed718c","buyer_question:probatix-health-gmbh-q140262414-answer-60c9cafe983539a814b5","buyer_question:probatix-health-gmbh-q140262414-answer-7a9a950bcc49f6f8cc66","buyer_question:probatix-health-gmbh-q140262414-answer-7e84954f6419e689f2aa","buyer_question:probatix-health-gmbh-q140262414-answer-88b8a6714ec70de53b87","buyer_question:probatix-health-gmbh-q140262414-answer-8c13d36011c4086c0c7c","buyer_question:probatix-health-gmbh-q140262414-answer-90c41c6c516d98592019","buyer_question:probatix-health-gmbh-q140262414-answer-ac52f62cf8e0dee154a0","buyer_question:probatix-health-gmbh-q140262414-answer-b6c7741ef1cf2c115144","buyer_question:probatix-health-gmbh-q140262414-answer-fbef19fa36d8c308af40"],"sourceIds":["ready-scan-subjects"],"provenance":[{"snapshotId":"probatix-health-gmbh-q140262414-content-3723c9e2240335b1-snapshot","sourceId":"ready-scan-subjects","sourceRecordId":"Q140262414","sourceRevisionId":"Q140262414:content:d2a68e8dd19eed12","sourceContentHash":"fnv1a64:074d16934e06b625","recordRevisionId":"Q140262414:content:d2a68e8dd19eed12","recordContentHash":"fnv1a64:98e2c562ba0732a8","sourceCanonicalUrl":"https://probatix.com/","sourceModifiedAt":"2026-10-27T23:00:22.343Z","observedOn":"2026-10-27","permission":{"basis":"public_information","evidenceUrl":"https://probatix.com/"},"attributionUrl":"https://probatix.com/"}],"quality":{"method":"same_kind_unique_trigram_floor","minimumUniqueTrigramRatio":0.3,"status":"passed"},"title":"Probatix Health GmbH — company guide","summary":"Probatix Health GmbH: “Probatix (probatix.com) is the B2B platform of Probatix Health GmbH for laboratory diagnostics and home testing: white-label test kits, home sampling, logistics, ISO 15189-accredited partner labs and a REST API with FHIR R4 results for health insurers, telemedicine providers, digital health apps and medical practices. The consumer shop probatix.de (\"Probatix Health\") is a separate offering of the same company.”","facts":[{"id":"content-native-digital-agencies-af26e476fcf346fb-a-c4e9e4982669167dba32","label":"Probatix Health GmbH","value":"“Probatix (probatix.com) is the B2B platform of Probatix Health GmbH for laboratory diagnostics and home testing: white-label test kits, home sampling, logistics, ISO 15189-accredited partner labs and a REST API with FHIR R4 results for health insurers, telemedicine providers, digital health apps and medical practices. The consumer shop probatix.de (\"Probatix Health\") is a separate offering of the same company.”","sourceUrls":["https://probatix.com/en/"]},{"id":"content-native-digital-agencies-af26e476fcf346fb-a-90c41c6c516d98592019","label":"What is Diagnostics-as-a-Service?","value":"“Diagnostics-as-a-Service (DaaS) is a model where companies access complete laboratory diagnostics infrastructure as a service – including home sampling, logistics, accredited labs, and digital result delivery via API.”","sourceUrls":["https://probatix.com/en/"]},{"id":"content-native-digital-agencies-af26e476fcf346fb-a-2995f99c2587dbc0f66e","label":"How do I integrate Probatix into my infrastructure?","value":"“Probatix provides a fully documented REST API and an FHIR-compatible endpoint. Integration is possible within days. A white-label portal is also available for companies without in-house development resources.”","sourceUrls":["https://probatix.com/en/"]},{"id":"content-native-digital-agencies-af26e476fcf346fb-a-084b48b1b916d580899e","label":"Which standards does Probatix work according to?","value":"“Our quality management is based on ISO 13485 (quality management for medical devices). All analyses take place in ISO 15189-accredited laboratories. Our platform is GDPR-compliant and FHIR-compatible.”","sourceUrls":["https://probatix.com/en/"]},{"id":"content-native-digital-agencies-af26e476fcf346fb-a-ac52f62cf8e0dee154a0","label":"Which companies is Probatix designed for?","value":"“Probatix is designed for B2B companies in healthcare: insurers, telemedicine providers, digital health startups, longevity platforms, prevention providers, and corporate health programmes.”","sourceUrls":["https://probatix.com/en/"]},{"id":"content-native-digital-agencies-af26e476fcf346fb-a-88b8a6714ec70de53b87","label":"Which panels are suitable for longevity and prevention programmes?","value":"“Typically a combination of lipid profile, HbA1c, hsCRP, thyroid function (TSH, fT3, fT4), micronutrients (vitamin D, B12, ferritin) and hormonal follow-up markers. Exactly what our panels \"Metabolic Profile\", \"Nutrient Analysis Plus\", \"Cardiovascular Risk Profile\" and programme-specific cuts are designed for — we configure that together with you.”","sourceUrls":["https://probatix.com/en/solutions/digital-health/"]},{"id":"content-native-digital-agencies-af26e476fcf346fb-a-8c13d36011c4086c0c7c","label":"Can I automate recurring diagnostics (e.g. quarterly)?","value":"“Yes. Through the REST API, recurring orders can be triggered by rules — for example at fixed programme times or as value-triggered follow-ups. Webhooks keep your system synchronised on every status change.”","sourceUrls":["https://probatix.com/en/solutions/digital-health/"]},{"id":"content-native-digital-agencies-af26e476fcf346fb-a-60c9cafe983539a814b5","label":"Who analyses the samples?","value":"“ISO 15189-accredited partner laboratories within the EU. Probatix routes automatically by capacity, region and parameter specification. Pre-analytics, validation and — where required — medical release run according to established standard processes.”","sourceUrls":["https://probatix.com/en/solutions/digital-health/"]},{"id":"content-native-digital-agencies-af26e476fcf346fb-a-fbef19fa36d8c308af40","label":"How can my health app offer blood tests?","value":"“A health app can offer blood tests without building its own lab or logistics: with Probatix, your users order the test kit directly in the app, collect the sample at home and send it back postage-free; an ISO 15189-accredited partner lab analyses it.”","sourceUrls":["https://probatix.com/en/solutions/health-apps/"]},{"id":"content-native-digital-agencies-af26e476fcf346fb-a-41ffa69c2f83f3ed718c","label":"How do I integrate Probatix into my app?","value":"“Via the REST API: POST /v1/orders to create, webhooks for status changes, GET /v1/orders/{id}/report for the result (as JSON or FHIR R4). A standard integration is in place within a few days of development time.”","sourceUrls":["https://probatix.com/en/solutions/health-apps/"]},{"id":"content-native-digital-agencies-af26e476fcf346fb-a-7a9a950bcc49f6f8cc66","label":"What data can I process directly via FHIR?","value":"“A complete FHIR R4 bundle with DiagnosticReport (overall result), Observation per parameter (value, unit, reference range, flags) and Patient/Practitioner references. Values are LOINC-coded — you can ingest them into any FHIR-capable system without mapping.”","sourceUrls":["https://probatix.com/en/solutions/health-apps/"]},{"id":"content-native-digital-agencies-af26e476fcf346fb-a-b6c7741ef1cf2c115144","label":"Which SGB V sections can a Probatix programme be financed through?","value":"“The most common routes: §140a (special care / selective contracts), §25 (early detection), §20a (health promotion), §20b (treatment steering). Which section applies depends on the care objective. More in the article \"Financing prevention\".”","sourceUrls":["https://probatix.com/en/solutions/insurance/"]},{"id":"content-native-digital-agencies-af26e476fcf346fb-a-7e84954f6419e689f2aa","label":"What is the participation rate among insured members with home testing?","value":"“Significantly higher than with clinic-based procedures. The Dutch population-wide study on colorectal cancer screening consistently shows over 70% participation in the postally delivered FIT/iFOBT — compared with 22% for colonoscopy. The lever is highly measurable and transferable to other prevention indications.”","sourceUrls":["https://probatix.com/en/solutions/insurance/"]},{"id":"content-native-digital-agencies-af26e476fcf346fb-a-2fe4eda2125b74fff956","label":"Do we receive an economic analysis?","value":"“Yes. Based on the structure of your insured population we prepare an individual model — with cost estimates per module, scaling scenarios and suitable financing routes. It does not replace legal advice, but complements it as an operational basis for decisions.”","sourceUrls":["https://probatix.com/en/solutions/insurance/"]}]}